Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...

Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...

Study results show a new technique that analyzes genomic information from a type of skin cancer tumor could help melanoma patients avoid additional surgery on their lymph nodes. The test was developed ...

A cancer treatment has been reformulated into a simple injection after its key components behaved differently in ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...

A study led by scientists at NYU Langone Health and its Perlmutter Cancer Center has shown that monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer ...

Scientists at NYU Abu Dhabi have developed an innovative use for nanotechnology in the field of cancer research. Their ...